Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy

Jianying Li,Anjun Ma,Ruohan Zhang,Yao Chen,Chelsea Bolyard,Bao Zhao,Cankun Wang,Thera Pich,Wantong Li,Nuo Sun,Qin Ma,Haitao Wen,Steven K. Clinton,William E. Carson,Zihai Li,Gang Xin

DOI: https://doi.org/10.1007/s00262-023-03603-3

IF: 6.63

2024-02-14

Cancer Immunology Immunotherapy

Abstract:As one of the major components of the tumor microenvironment, tumor-associated macrophages (TAMs) possess profound inhibitory activity against T cells and facilitate tumor escape from immune checkpoint blockade therapy. Converting this pro-tumorigenic toward the anti-tumorigenic phenotype thus is an important strategy for enhancing adaptive immunity against cancer. However, a plethora of mechanisms have been described for pro-tumorigenic differentiation in cancer, metabolic switches to program the anti-tumorigenic property of TAMs are elusive.

oncology,immunology